Acute radiation dermatitis in breast cancer: topical therapy with vitamin E acetate in lipophilic gel base
S Martella1, M Rietjens1, V Lohsiriwat2,R Lazzari3, A Vavassori3,BA Jereczek3,4, V Lazzati1, MC Leonardi3 and JY Petit1
1Departments of Plastic Surgery, 3Departments of Radiotherapy, European Institute of Oncology, via Ripamonti 435, 20141, Milan, Italy
2Siriraj Hospital Mahidol University, Bangkok, Thailand
4University of Milan, Milan, Italy
Correspondence to: S Martella. Email: email@example.com
Key Words: Radiation dermatitis; breast cancer; vitamin E.
Background: Radiotherapy can cause adverse skin reactions over the course of their treatment. Currently, management is based on several tropical products although there is no gold-standard approach to prevention and management of radiation toxicity.
Method: We report our experience of vitamin E acetate in the treatment of radiation dermatitis in breast cancer patients who experienced grade 4 side effects (according to Radiation Therapy Oncology Group criteria).
Results: Clinical management consisted of oral antibiotics and local application of vitamin E acetate and local escarectomy. All of the patients achieved complete re-epithelialization within 40 days.
Conclusion: Skin ulceration and necrosis post-radiation may interrupt oncological treatment in breast cancer patients. In acute radiodermatitis with skin necrosis, we propose the use of oral antibiotics together with escarectomy and the application of vitamin E acetate to facilitate the healing process in order to minimize the interruption to the oncological treatment.
The standard treatment for early breast cancer includes conserving breast surgery followed by radiation therapy and systemic treatment. One of the common side effects of irradiation is a skin reaction, including acute erythema, desquamation and, rarely, delayed radiodystrophy or radionecrosis. Mild to moderate acute dermatitis occurring during the treatment course is common. While more severe acute injury is rare and normally only occurs in cases with specific skin sensibility or to an area receiving a higher dose of radiation, it may lead to local infection associated with skin ulceration similar to a severe skin burn [1–5]. Severe acute dermatitis may require interruption of the radiation therapy and oncological treatment course. Local treatment of acute radiation dermatitis usually includes corticoid creams [6–8]. We present a case of acute dermatitis occurring during a course of radiotherapy for conservative treatment of breast cancer. The aim of this report is to focus on the local treatment (vitamin E acetate in lipophilic gel (named as Vea Oil Ò) plus escarectomy and oral antibiotic administration.
Case report: A 67-year-old women was submitted to conservative surgery for a ductal infiltrating carcinoma of the left breast, stage pT1c, pN0, M0, G3, ER: 0%; PgR: 0%; Ki-67: 70%; c-erb B2: absent. Post-operative therapy included chemotherapy (CMF - 6 cycles) and external radiotherapy (50 Gy with an additional boost of 10 Gy in tangential fields with photon energy of 6 MV given in 2 Gy daily fractions, 5 fractions/week). The radiotherapy started after the third cycle of chemotherapy, despite the neutropenia. After 40 Gy of radiotherapy, the patient presented a skin lesion of the 4° grade (criteria of the Radiation Therapy Oncology Group, RTOG) erythema, cutaneous necrosis, pain, fever and a Staphylococcus aureus infection (Figure 1). The radiation treatment plan was reviewed and an overdose area was revealed. In this case, local treatment with vitamin E acetate as a lipophic gel, escarectomy and oral antibiotics were administered.
Figure 1: Erythema associated with flyctena, cutaneous necrosis, pain, fever and staphylococcus aureus infection.
This patient was treated with oral antibiotics and local application of vitamin E acetate from the first day after the presentation of the skin lesion. After six days, an escarectomy was performed under local anaesthesia (Figure 2). After 25 days, the infection had resolved and total re-epithelialization was observed (Figure 3). After 40 days, the result was excellent. Further patients were treated with the same procedure, and in all cases, their skin complications healed within 40 days and the same satisfactory results were achieved (Figure 4).
Figure 2: After escarectomy in local anaestesia.
Figure 3: After 25 days of treatment.
Figure 4: After 40 days of treatment.
Extensive radiation dermatitis usually requires several months to heal and often does not heal spontaneously. Some of the healed aesthetic results are unsatisfactory and may require plastic surgery procedures. In our case, the association of oral antibiotics and local treatment with Vea OilÒ—vitamin E acetate allowed complete healing of the wounds within 40 days. The idea of using the oil alpha-tocopherol acetate for topical skin treatment was based on the following evidence: (a) the redox chemistry of the vitamin, compatible with an anti-oxidant effect in vivo [9,10]; (b) the hydrolysis of the ester in the skin  and thus the pro-drug nature of the acetate; (c) the prospect of a physiological extracellular function of vitamin E, which is, indeed, secreted and reabsorbed by the skin . The beneficial effect, in relation to the preservation of the barrier function of the skin, is clearly evident.
Skin ulceration and necrosis post-radiation may interrupt oncological treatment of the breast cancer patient. In acute radiodermatitis with skin necrosis, we propose the use of oral antibiotics together with escarectomy and the application of vitamin E acetate to facilitate the healing process in order to minimize the interruption to the oncological treatment.
The authors declared they have no competing interests.
We are indebted to the collaboration of personnel and nurses in the Plastic Surgery department, European Institute of Oncology, Milan, Italy.
1. Berthelet E, Truong PT and Musso K et al (2004) Preliminary reliability and validity testing of a new skin toxicity assessment tool (STAT) in breast cancer patients undergoing radiotherapy Am J Clin Oncol 27 (6) 626–31 PMID: 15577442 doi:10.1097/01.coc.0000138965.97476.0f
2. Turesson I and Thames HD (1989) Repair capacity and kinetics of human skin during fractionated radiotherapy: erythema, desquamation, and telangiectasia after 3 and 5 year's follow-up Radiother Oncol 15 (2) 169–88 PMID: 2762590doi:10.1016/0167-8140(89)90131-X
3. Mayr NA, Riggs CE Jr and Saag KG et al (1997) Mixed connective tissue disease and radiation toxicity: a case report Cancer 79 (3) 612–8 PMID: 9028375 doi:10.1002/(SICI)1097-0142(19970201)79:3<612::AID-CNCR26>3.0.CO;2-5
4. Lopez E, Nunez MI and Guerrero MR et al (2002) Breast cancer acute radiotherapy morbidity evaluated by different scoring systems Breast Cancer Res Treat 73 (2) 127–34 PMID: 12088115 doi:10.1023/A:1015296607061
5. Hanna YM, Baglan KL and Stromberg JS et al (2002) Acute and subacute toxicity associated with concurrent adjuvant radiation therapy and paclitaxel in primary breast cancer therapy Breast J 8 (3) 149–53 PMID: 12047471 doi:10.1046/j.1524-4741.2002.08306.x
6. Porock D and Kristjanson L (1999) Skin reactions during radiotherapy for breast cancer: the use and impact of topical agents and dressings Eur J Cancer Care (Engl) 8 (3) 143–53 PMID: 10763645 doi:10.1046/j.1365-2354.1999.00153.x
7. Potera ME, Lookingbill DP and Stryker JA (1982) Prophylaxis of radiation dermatitis with a topical cortisone cream Radiology 143 (3) 775–7
8. Bostrom A, Lindman H and Swartling C et al (2001) Potent corticosteroid cream (mometasone furoate) significantly reduces acute radiation dermatitis: results from a double-blind, randomized study Radiother Oncol 59 (3) 257–65 PMID: 11369066 doi:10.1016/S0167-8140(01)00327-9
11. Beijersbergen van Henegouwen GM, Junginger HE and De Vries H (1995) Hydrolysis of RRR-alpha-tocopheryl acetate (vitamin E acetate) in the skin and its UV protecting activity (an in vivo study with the rat) J Photochem Photobiol B 29 (1) 45–51 PMID: 7472802 doi:10.1016/1011-1344(95)90251-1
12. Thiele JJ, Weber SU and Packer L (1999) Sebaceous gland secretion is a major physiologic route of Vitamin E delivery to skin J Invest Dermatol 113 (6) 1006–10 PMID: 10594744 doi:10.1046/j.1523-1747.1999.00794.x